Synergistic Effects of Capsaicin and Quercetin Improved Induced Premature Ovarian Failure in Rat

Document Type : Original Article

Authors

1 Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

2 Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

Abstract

Objective: Premature ovarian failure (POF) is a heterogeneous disorder. POF is defined as hypergonadotropic
hypoestrogenism in women under 40 years. There is no effective treatment to cure POF patients. Antioxidants prevent
ovarian damage by reducing the lipid peroxidation cascades affecting folliculogenesis, meiosis and ovulation. Hence;
the aim of present study was to investigate the effects of Capsaicin (CAP) and Quercetin (QUR) on cyclophosphamide
(CYC)-induced POF in rat model.
Materials and Methods: In this experimental study, POF was induced by intraperitoneal injection of 200 mg/kg CYC on
first day and then 8 mg/kg/day for the following 3 days. After 4 days of CYC administration, rats were randomly divided
into five groups (n=6/group) as follows: POF, dimethyl sulfoxide (DMSO), CAP (0.5 mg/kg/day), QUR (100 mg/kg/day)
and CAP+QUR. Biochemical, hormonal, gene expression, and histological evaluations were performed on blood serum
and tissue samples after 14 days of treatment with the CAP and QUR.
Results: CAP, QUR and CAP+QUR groups showed signs of restored ovarian function in the form of a significant
increase in serum total antioxidant capacity (TAC), estrogen, progesterone and anti-mullerian hormone (AMH) levels
versus POF and DMSO groups and a significant improvement in histological parameters and follicle numbers in
treatment groups compared to POF and DMSO groups. Polymerase chain reaction (PCR) analysis demonstrated that
CAP and QUR upregulate the expression of BAX gene and decreased the expression of apoptosis inducing genes
(BCL-2 and P53).
Conclusion: CAP and QUR treatment of CYC-induced POF rats showed a positive effect on reducing ovarian damage
by improving TAC levels, expression of apoptotic genes, levels of ovarian reserve markers, and histological parameters.
Our results suggest that treatment with CAP or QUR may be a conservative treatment approach for CYC -induced POF.

Keywords

Main Subjects

References

  1. Cooper AR, Baker VL, Sterling EW, Ryan ME, Woodruff TK, Nelson LM. The time is now for a new approach to primary ovarian insufficiency. Fertil Steril. 2011; 95(6): 1890-1897.
  2. Podfigurna-Stopa A, Czyzyk A, Grymowicz M, Smolarczyk R, Katulski K, Czajkowski K, et al. Premature ovarian insufficiency: the context of long-term effects. J Endocrinol Invest. 2016; 39(9): 983-990.
  3. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005; 11(4): 391-410.
  4. Yang X, Wang C, He X, Wei J, Wang Y, Li X, et al. Hormone therapy for premature ovarian insufficiency patients with malignant hematologic diseases. Climacteric. 2017; 20(3): 268-273.
  5. Deady J. Clinical monograph: hormone replacement therapy. J Manag Care Pharm. 2004; 10(1): 33-47.
  6. Park KR, Nam D, Yun HM, Lee SG, Jang HJ, Sethi G, et al. β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett. 2011; 312(2): 178- 188.
  7. Rashidi Z, Aleyasin A, Eslami M, Nekoonam S, Zendedel A, Bahramrezaie M, et al. Quercetin protects human granulosa cells against oxidative stress via thioredoxin system. Reprod Biol. 2019; 19(3): 245-254.
  8. Rashidi Z, Khosravizadeh Z, Talebi A, Khodamoradi K, Ebrahimi R, Amidi F. Overview of biological effects of Quercetin on ovary. Phytother Res. 2021; 35(1): 33-49.
  9. Gormaz JG, Quintremil S, Rodrigo R. Cardiovascular disease: a target for the pharmacological effects of quercetin. Curr Top Med Chem. 2015; 15(17): 1735-1742.
  10. Akdemir Y, Akpolat M, Elmas O, Kececi M, Cetinkaya B. P–443 Effects of capsaicin pre-treatment on ovarian follicle pool, inflammatory and apoptotic pathways against radiation induced ovarian failure. Hum Reprod. 2021; 36 Suppl 1: i337.
  11. Brederson JD, Kym PR, Szallasi A. Targeting TRP channels for pain relief. Eur J Pharmacol. 2013; 716(1-3): 61-76.
  12. Akdemir Y, Akpolat M, Elmas O, Kececi M, Buyukuysal C, Cetinkaya B, et al. Capsaicin prevents radiotherapy-induced premature ovarian failure in rats. Reprod Fertil Dev. 2022; 34(3): 350-361.
  13. Mutlu Altundağ E, Kasacı T, Yılmaz AM, Karademir B, Koçtürk S, Taga Y, et al. Quercetin-induced cell death in human papillary thyroid cancer (B-CPAP) cells. J Thyroid Res. 2016; 2016: 9843675.
  14. Marchiani A, Rozzo C, Fadda A, Delogu G, Ruzza P. Curcumin and curcumin-like molecules: from spice to drugs. Curr Med Chem. 2014; 21(2): 204-222.
  15. Lesjak M, Beara I, Simin N, Pintać D, Majkić T, Bekvalac K, et al. Antioxidant and anti-inflammatory activities of quercetin and its derivatives. JFF. 2018; 40: 68-75.
  16. Anand David AV, Arulmoli R, Parasuraman S. Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn Rev. 2016; 10(20): 84-89.
  17. Parvaresh A, Razavi R, Rafie N, Ghiasvand R, Pourmasoumi M, Miraghajani M. Quercetin and ovarian cancer: an evaluation based on a systematic review. J Res Med Sci. 2016; 21: 34.
  18. Baghel SS, Shrivastava N, Baghel RS, Rajput S. A review of quercetin: antioxidant and anticancer properties. World J Pharm Pharmaceutical Sci. 2012; 1(1): 146-160.
  19. Wang W, Wang C, Ding XQ, Pan Y, Gu TT, Wang MX, et al. Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats. Br J Pharmacol. 2013; 169(6): 1352-1371.
  20. Izaguirry AP, Soares MB, Vargas LM, Spiazzi CC, Dos Santos Brum D, Noremberg S, et al. Blueberry (Vaccinium ashei Reade) extract ameliorates ovarian damage induced by subchronic cadmium exposure in mice: Potential δ-ALA-D involvement. Environ Toxicol. 2017; 32(1): 188-196.
  21. Wang J, Qian X, Gao Q, Lv C, Xu J, Jin H, et al. Quercetin increases the antioxidant capacity of the ovary in menopausal rats and in ovarian granulosa cell culture in vitro. J Ovarian Res. 2018; 11(1): 51.
  22. Gencer M, Karaca T, Güngör AN, Hacıvelioğlu SÖ, Demirtaş S, Turkon H, et al. The protective effect of quercetin on IMA levels and apoptosis in experimental ovarian ischemia-reperfusion injury. Eur J Obstet Gynecol Reprod Biol. 2014; 177: 135-140.
  23. Engen A, Maeda J, Wozniak DE, Brents CA, Bell JJ, Uesaka M, et al. Induction of cytotoxic and genotoxic responses by natural and novel quercetin glycosides. Mutat Res Genet Toxicol Environ Mutagen. 2015; 784-785: 15-22.
  24. Gencer M, Karaca T, Güngör AN, Hacıvelioğlu SÖ, Demirtaş S, Turkon H, et al. The protective effect of quercetin on IMA levels and apoptosis in experimental ovarian ischemia-reperfusion injury. Eur J Obstet Gynecol Reprod Biol. 2014; 177: 135-140.
  25. Mobasher MA, Hassen MT, Ebiya RA, Alturki NA, Alzamami A, Mohamed HK, et al. Ameliorative effect of citrus lemon peel extract and resveratrol on premature ovarian failure rat model: role of iNOS/Caspase-3 pathway. Molecules. 2022; 28(1): 122.
  26. Elkady MA, Shalaby S, Fathi F, El-Mandouh S. Effects of quercetin and rosuvastatin each alone or in combination on cyclophosphamide- induced premature ovarian failure in female albino mice. Hum Exp Toxicol. 2019; 38(11): 1283-1295.
  27. Khazaei F, Ghanbari E, Khazaei M. Protective effect of royal jelly against cyclophosphamide-induced thrombocytopenia and spleen and bone marrow damages in rats. Cell J. 2020; 22(3): 302-309.
  28. Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010; 53(4): 727-739.
  29. Roness H, Kashi O, Meirow D. Prevention of chemotherapy-induced ovarian damage. Fertil Steril. 2016; 105(1): 20-29.
  30. Brederson JD, Kym PR, Szallasi A. Targeting TRP channels for pain relief. Eur J Pharmacol. 2013; 716(1-3): 61-76.
  31. Tsuji F, Aono H. Role of transient receptor potential vanilloid 1 in inflammation and autoimmune diseases. Pharmaceuticals (Basel). 2012; 5(8): 837-852.
  32. Leonelli M, Martins DO, Britto LR. TRPV1 receptors modulate retinal development. Int J Dev Neurosci. 2011; 29(4): 405-413.
  33. Arzuman L, Beale P, Yu JQ, Huq F. Synthesis of tris(quinoline)monochloroplatinum(II) chloride and its activity alone and in combinationwith capsaicin and curcumin in human ovarian cancer cell lines. Anticancer Res. 2016; 36(6): 2809-2818.
  34. Melekoglu R, Ciftci O, Eraslan S, Cetin A, Basak N. Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model. J Ovarian Res. 2018; 11(1): 33.
  35. Liang LF, Qi ST, Xian YX, Huang L, Sun XF, Wang WH. Protective effect of antioxidants on the pre-maturation aging of mouse oocytes. Sci Rep. 2017; 7(1): 1434.
  36. Chaudhary A, Gour JK, Rizvi SI. Capsaicin has potent anti-oxidative effects in vivo through a mechanism which is non-receptor mediated. Arch Physiol Biochem. 2022; 128(1): 141-147.
  37. Park SG, Yon JM, Lin C, Gwon LW, Lee JG, Baek IJ, et al. Capsaicin attenuates spermatogenic cell death induced by scrotal hyperthermia through its antioxidative and anti-apoptotic activities. Andrologia. 2017; 49(5).
  38. Özcan P, Fıçıcıoğlu C, Yıldırım ÖK, Özkan F, Akkaya H, Aslan İ. Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague-Dawley rats. Reprod Biomed Online. 2015; 31(3): 404-410.
  39. Elkady MA, Shalaby S, Fathi F, El-Mandouh S. Effects of quercetin and rosuvastatin each alone or in combination on cyclophosphamide- induced premature ovarian failure in female albino mice. Hum Exp Toxicol. 2019; 38(11): 1283-1295.

Files

Cited by

Share

How to cite

Statistics